Mirtazapine for sleep: benefits, dosing and practical advice

Mirtazapine has a unique pharmacological profile among antidepressants that makes it particularly useful for patients with depression and insomnia.

The key mechanisms:

• H1 histamine receptor blockade: mirtazapine is a potent antihistamine. Histamine is a key neurotransmitter involved in maintaining wakefulness, so blocking H1 receptors promotes drowsiness and sleep
• 5-HT2A and 5-HT2C receptor antagonism: blocking these serotonin receptors promotes slow-wave (deep) sleep and may reduce the time it takes to fall asleep
• Alpha-2 adrenergic antagonism: at lower doses, the antihistamine effect dominates; as the dose increases, noradrenergic activation may counterbalance the sedation

What the evidence shows:

Clinical studies have demonstrated that mirtazapine:

• Reduces sleep latency (the time it takes to fall asleep)
• Increases total sleep time
• Improves sleep efficiency and sleep continuity
• Enhances slow-wave sleep, which is important for physical restoration
• Does not significantly suppress REM sleep at standard doses

These properties make mirtazapine a preferred choice when a prescriber wants to treat depression and poor sleep simultaneously, avoiding the need for a separate sleeping tablet.

The sedating effect of mirtazapine is strongest at lower doses, which has important implications for prescribing.

Dose and sedation relationship:

• 7.5 mg: sometimes prescribed off-label specifically for insomnia. At this sub-therapeutic antidepressant dose, the antihistamine effect is dominant and sedation is pronounced
• 15 mg: the usual starting dose for depression. Still very sedating for most patients. This is the most commonly prescribed dose when both antidepressant and sleep benefits are desired
• 30 mg: increased noradrenergic activity may reduce sedation compared to 15 mg. Some patients who were drowsy at 15 mg feel more alert at 30 mg
• 45 mg: the maximum licensed dose. Sedation is variable at this dose

Timing:

• Mirtazapine should be taken 1 to 2 hours before bedtime to align the peak sedative effect with the desired sleep onset
• Taking it earlier in the evening may cause unwanted drowsiness before bed; taking it too late may lead to morning grogginess

Important note:

While lower doses are more sedating, they may not provide adequate antidepressant efficacy.

If mirtazapine is prescribed for depression, the dose should be at least 15 mg and titrated to the effective dose as recommended in NICE guidelines.

The sedation at this level is usually a welcome secondary benefit rather than the primary goal.

Many patients wonder how mirtazapine compares to dedicated sleeping medicines such as zopiclone or zolpidem.

Advantages of mirtazapine over Z-drugs and benzodiazepines:

• Dual benefit: treats both depression and insomnia simultaneously
• Lower dependence risk: mirtazapine does not carry the same risk of physical dependence as benzodiazepines or Z-drugs
• No tolerance to sleep effects: unlike zopiclone, where sleep benefits often diminish after a few weeks, mirtazapine's sleep effects tend to be sustained
• Promotes natural sleep architecture: enhances slow-wave sleep rather than simply sedating the patient
• No next-day hangover for most patients once the dose is stable (though some experience morning drowsiness initially)

Disadvantages compared to dedicated sleep aids:

• Weight gain: a significant concern that sleeping tablets do not typically cause
• Slower onset of antidepressant action: the sleep benefit is immediate, but the mood improvement takes 2 to 4 weeks
• Not suitable for short-term use: mirtazapine is intended for longer courses, unlike a short course of zopiclone
• Requires gradual withdrawal: cannot be stopped abruptly

What NICE says:

NICE does not recommend mirtazapine specifically as a hypnotic.

However, NICE guidance on depression notes that the choice of antidepressant should take into account the patient's symptoms, including insomnia, and that mirtazapine may be preferred when sleep disturbance is prominent.

If you have been prescribed mirtazapine and one of the goals is to improve your sleep, the following tips can help you get the most benefit.

Optimising sleep with mirtazapine:

• Be consistent with timing: take your dose at the same time each evening, ideally 1 to 2 hours before bed
• Allow time for adjustment: the sedating effect is usually strongest in the first week and may moderate slightly over time
• Do not drink alcohol: alcohol disrupts sleep quality and increases sedation and the risk of side effects
• Maintain good sleep hygiene: mirtazapine works best alongside healthy sleep habits
• Keep a regular sleep schedule
• Create a cool, dark, quiet bedroom
• Limit screens for at least 30 minutes before bed
• Avoid caffeine after midday

If morning drowsiness is a problem:

• Try taking the dose slightly earlier in the evening
• Discuss with your prescriber whether a dose adjustment might help
• Ensure you are allowing enough time for sleep (7 to 9 hours)

When to discuss alternatives:

• If mirtazapine improves your sleep but the weight gain is unacceptable
• If sleep does not improve despite taking mirtazapine correctly
• If you develop withdrawal symptoms when attempting to reduce the dose

Your GP can advise on whether mirtazapine remains the best option or whether an alternative approach to sleep and mood management would be more suitable.

Many patients take mirtazapine for months or years. Understanding the long-term picture is important.

Does the sleep benefit last?

For most patients, the sleep-promoting effect of mirtazapine is sustained during long-term treatment.

Unlike benzodiazepines and Z-drugs, where tolerance develops relatively quickly, mirtazapine continues to support sleep quality over months and years.

Long-term considerations:

• Weight: this is the main concern with prolonged use. Regular monitoring and proactive management are essential
• Metabolic effects: long-term mirtazapine use has been associated with increased cholesterol and triglycerides in some patients
• Bone health: some antidepressants may affect bone density over time, though the evidence for mirtazapine specifically is limited
• Review and reassessment: NICE recommends that antidepressant treatment is reviewed regularly, typically at least every 6 to 12 months, to decide whether continued treatment is warranted

Stopping mirtazapine:

When the time comes to stop, a gradual dose reduction over several weeks is recommended. Some patients experience rebound insomnia during withdrawal, which usually settles within a few weeks.

Your prescriber can provide a tailored withdrawal plan.

If you have been taking mirtazapine primarily for sleep and your mood has improved, discuss with your doctor whether it is time to try reducing the dose or switching to non-pharmacological sleep strategies such as cognitive behavioural therapy for insomnia (CBT-I).